ArticleF1000Research2025
Physiological, Immunological, and Erythrocyte Sedimentation Rate Alterations in Male Patients with Rheumatoid Arthritis.
Article in F1000Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid arthritis (RA) is an autoimmune condition characterized by symmetrical and chronic pain and inflammation, initially affecting the small joints of the hands and feet, and later the larger joints. RA also attacks other organs of the body, particularly the skin, eyes, heart, kidneys, and lungs. Aim: The purpose of this research is to assess and characterize the hematological and immunological parameters that indicate the presence of inflammation and autoimmune conditions in persons with RA. Methods: 90 male participants were recruited from several healthcare facilities, including Fallujah Teaching Hospital and Diagnostic Laboratories. The participants, RA patients (60) and healthy controls (30) were distributed into 2 groups for the comparative analysis of the hematological and immunological parameters. Results: Significant elevations (P < 0.0001) in erythrocyte sedimentation rate and immunoglobulins G and M were observed in RA patients across three age groups: young adults (25-40 years), middle-aged (41-65 years), and increased adults (66-90 years). Anti-cyclic citrullinated peptide, anti-mutated citrullinated vimentin, rheumatoid factor, and C-reactive protein showed significant increases (P < 0.0001) across all age categories. Conclusion: The results reveal systemic inflammation and autoimmune dysregulation that are independent of patient age. Using immunological and hematological biomarkers in routine practice can improve diagnostic accuracy, guide personalized treatment, and help prevent joint damage while enhancing patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.